You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, Myeloid

Showing 1 - 25 of 6,958
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Antalya

Recruiting
  • Acute Myeloid Leukemia
    • Antalya, Turkey
      Antalya Training and Research Hospital
    Jul 29, 2023

    Acute Myeloid Leukemia Trial (Dasatinib)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • (no location specified)
    Sep 20, 2023

    Patients With Acute Myeloid Leukemia

    Recruiting
    • Acute Myeloid Leukemia, Adult
      • Freiburg, CA, Germany
        Medical Center- University of Freiburg
      Aug 4, 2023

      Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

      Recruiting
      • Acute Myeloid Leukemia Refractory
      • Acute Myeloid Leukemia, in Relapse
      • anti Tim-3/CD123 CAR-T cell therapy
      • Xuzhou, Jiangsu, China
        Kailin Xu
      Nov 4, 2023

      AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

      Not yet recruiting
      • AML
      • +11 more
      • (no location specified)
      Aug 14, 2023

      A Study of c-Kit Mutation as MRD in Acute Myeloid Leukemia

      Not yet recruiting
      • C-KIT Mutation
        • (no location specified)
        Nov 2, 2023

        Acute Myeloid Leukemia Trial (ABBV-787)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • (no location specified)
        Sep 29, 2023

        Oral Azacitidine Maintenance Therapy in Korean Acute Myeloid

        Not yet recruiting
        • Acute Myeloid Leukemia
        • Oral azacitidine
        • Seoul, Korea, Republic of
          Bristol-Myers Squibb YH
        Oct 3, 2023

        Acute Myeloid Leukemia Refractory Trial in Lyon (NP137, Azacitidine Injection, Venetoclax)

        Recruiting
        • Acute Myeloid Leukemia Refractory
        • Lyon, France
          Centre Léon Bérard
        Nov 30, 2023

        Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)

        Not yet recruiting
        • Acute Myeloid Leukemia, in Relapse
        • Acute Myeloid Leukemia Refractory
        • (no location specified)
        Nov 9, 2023

        Acute Myeloid Leukemia Trial in Beijing (N-acetyl-L-cysteine)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • Beijing, Beijing, China
          Yuan Kong
        Sep 4, 2023

        Acute Myeloid Leukemia Trial in Taipei

        Enrolling by invitation
        • Acute Myeloid Leukemia
          • Taipei, Taiwan
            National Taiwan University Hospital
          Aug 9, 2023

          Frequency and Risk Factors of Acute Myeloid Leukemia

          Not yet recruiting
          • Myeloid Leukemia
          • Bone marrow aspirite for diagnosis
          • (no location specified)
          Mar 15, 2023

          Acute Myeloid Leukemia Trial in Beijing (Ven+CAG)

          Recruiting
          • Acute Myeloid Leukemia
          • Beijing, Beijing, China
            Peking University People's Hospital
          Jun 23, 2023

          Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

          Recruiting
          • Acute Myeloid Leukemia
          • +3 more
          • CD123 targeted CAR-NK cells
          • Taiyuan, Shanxi, China
            Shanxi Bethune Hospital
          Aug 28, 2023

          Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Leukemia Trial in Boston (Cytokine-Induced Memory-like Natural Killer

          Not yet recruiting
          • Acute Myeloid Leukemia
          • +3 more
          • Cytokine-Induced Memory-like Natural Killer Cells
          • +2 more
          • Boston, Massachusetts
          • +1 more
          Nov 22, 2023

          Acute Myeloid Leukemia Trial in Houston (ASTX727, ASTX029-01)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • Houston, Texas
            MD Anderson Cancer Center
          Oct 27, 2023

          Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • Mitoxantrone hydrochloride liposome injection
          • +3 more
          • (no location specified)
          May 29, 2023

          iN the Real Practice

          Not yet recruiting
          • Acute Myeloid Leukemia (AML)
          • +2 more
          • Vyxeos liposomal
          • Roma, Italy
            Policlinico Tor Vergata
          Nov 16, 2023

          Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • Mitoxantrone hydrochloride liposome injection
          • +3 more
          • Tianjin, China
            Institute of Hematology & Blood Diseases Hospital
          Jul 1, 2023

          Chemo-Induced Thrombocytopenia Trial (Hetrombopag Olamine)

          Not yet recruiting
          • Chemotherapy-Induced Thrombocytopenia
          • Hetrombopag Olamine
          • (no location specified)
          Jul 5, 2023

          Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in

          Not yet recruiting
          • Acute Myeloid Leukemia
            • (no location specified)
            Sep 22, 2023

            Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

            Not yet recruiting
            • Chronic Myelogenous Leukemia - Chronic Phase
            • APN and medical management
            • +3 more
            • Avignon, Provence-Alpes-Côte d'Azur, France
              Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
            Oct 13, 2023

            PET Tracer Based FDG Signal for Predicting Prognosis in Acute

            Enrolling by invitation
            • Acute Myeloid Leukemia
            • No intervention
            • Guangzhou, Guangdong, China
              First Affiliated Hospital of Jinan University
            Jun 22, 2023

            Leukemia, Myeloid, Acute Trial in Guangzhou, Hangzhou (BG1805)

            Not yet recruiting
            • Leukemia, Myeloid, Acute
            • BG1805
            • Guangzhou, Guangdong, China
            • +2 more
            Nov 1, 2023